fda glp-1 warning september 2025 weight loss drugs are back in the news US FDA warns 30 telehealth

I am 48 years old, and everyone thinks and they say I look like I am in my early 30s

Since many individuals with Hashimoto's experience weight gain and difficulty losing weight despite adequate thyroid hormone replacement, the appetite-suppressing properties of GLP-1 agonists may appear attractive

These approaches, from conventional drug combinations to novel immunomodulatory and non-antifungal partnerships, represent a promising advance in antifungal therapeutics

Instead of jumping quickly to higher doses, microdosing GLP-1 medications generally involves starting with smaller amounts or moving more gradually over time